Anti-tumor, -viral, and -bacterial activities of polyoxometalates for realizing an inorganic drug

Journal of Materials Chemistry

Volumn 15, Issue 45, 2005, Pages 4773-4782

  Yamase, Toshihiro ^a,b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ACTIVITY; ELECTROCHEMICAL ACTIVITY; METAL-OXIDE CLUSTERS;

BACTERIA; CHEMOTHERAPY; ELECTROCHEMISTRY; SOLUBILITY; VIRUSES;

NEGATIVE IONS;

EID: 28944432410     PISSN: 09599428     EISSN: 13645501     Source Type: Journal    
DOI: 10.1039/b504585a     Document Type: Article

References (70)

1. (a) Polyoxometallates: From Platonic Solids to Anti-Retroviral Activity, ed. M. T. Pope and A. Müller, Kluwer Academic Publishers, Dordrecht, 1994;
2. (b) T. Yamase, in Polymeric Materials Encyclopedia: Synthesis, Properties, and Applications, ed. J. C. Salamone, CRC Press, Inc., Boca Raton, FL, 1996, p. 365;
3. (c) C. L. Hill (editor), Chem. Rev., 1998, 98, 1;
4. (d) Polyoxometallates: From Topology to Industrial Applications, ed. M. T. Pope and A. Müller, Kluwer Academic Publishers, Dordrecht, 2001;
5. (e) Polyoxometalate Chemistry for Nanocomposite Design, ed. T. Yamase and M. T. Pope, Kluwer Academic/Plenum Publishers, Dordrecht, 2002;
6. (f) Polyoxometalate Molecular Science, NATO Science series, ed. J. J. Borrás-Alamenar, E. Coronado, A. Müller, and M. T. Pope, Kluwer Academic Publishers, Dordrecht, 2003;
7. (g) T. Yamase, Catal. Surv. Asia, 2003, 7, 203.
8. (a) T. Yamase, H. Fujita and K. Fukushima, Inorg. Chim. Acta, 1988, 151, LI5;
9. (b) Y. Inouye, Y. Take, Y. Tokutake, T. Yoshida, A. Yamamoto and T. Yamase, Chem. Pharm. Bull., 1990, 38, 285;
10. (c)M. Fukuma, Y. Seto and T. Yamase, Antiviral Res., 1991, 16, 327;
11. (d) T. Yamase, K. Tomita, Y. Seto and H. Fujita, in Polymers in Medicine: Biomedical and Pharmaceutical Applications, Technomic Pub. Company Inc., Lancaster, PA, 1992, ch. 13, p. 187;
12. (e) T. Yamase, Molecular Engineering, Kluwer Academic Publishers, Dordrecht, 1994, vol. 3, p. 241;
13. (f) T. Yamase, N. Fukuda and Y. Tajima, Biol. Pharm. Bull., 1996, 19, 459;
14. (g) N. Fukuda and T. Yamase, Biol. Pharm. Bull., 1997, 20, 927;
15. (h) N. Fukuda, T. Yamase and Y. Tajima, Biol. Pharm. Bull, 1999, 22, 463;
16. (i) K. Dan, K. Miyashita, Y. Seto, H. Fujita and T. Yamase, Pharmacol. Res., 2002, 46, 357.
17. (a) N. Raybaud, C. Jasmin, J. Huppert, J. C. Chermann, G. Mathě and M. Raynaud, Rev. Eur. Études Clin. Biol., 1972, XVII, 295;
18. (b) C. Jasmin, M. Raybaud, J. C. Chermann, D. Haapala, F. Sinoussi, C. B. Loustau, C. Bonissol, P. Kona and M. Raynaud, Biomedicine, 1973, 18, 319;
19. (c) D. K. Haapala, C. Jasmin, F. Sinoussi, J. C. Chermann and M. Raynaud, Biomedicine, 1973, 19, 7;
20. (d) C. Jasmin, J. C. Chermann, G. Herve, A. Teze, P. Souchay, C. Boy-Loustau, N. Raybaud, F. Sinoussi and M. Raynaud, J. Nat. Cancer Inst., 1974, 53, 469;
21. (e) J. C. Chermann and F. C. Sinoussi, Biochem. Biophys. Res. Commun., 1975, 65, 1229;
22. (f) N. Larnicol, Y. Augery, C. L. Bousse-Kerdiles, V. Degiorgis, J. C. Chermann, A. Teze and C. Jasmin, J. Gen. Virol., 1981, 55, 17.
23. W. Rozenbaum, D. Dormont, B. Spire, E. Vilmer, M. Gentilini, L. Montagnier, F. Barre-Sinoussi and J. C. Chermann, Lancet, 1985, 450.
24. HPA-23 Cooperative Study Group and B. L. Moskovitz, Antimicrob. Agents Chemother., 1988, 32, 1300.
25. (a) N. Yamamoto, D. Schols, E. De Clercq, Z. Debyser, R. Pauwels, J. Barizarini, H. Nakashima, M. Babaa, M. Hosoya and R. Snoeck, Mol. Pharmacol, 1992, 42, 1109;
26. (b) Y. Inouye, Y. Tokutake, J. Kunihara, T. Yoshida, T. Yamase, A. Nakata and S. Nakamura, Chem. Pharm. Bull., 1992, 40, 805;
27. (c) M. S. Weeks, C. L. Hill and R. F. Schinazi, J. Med. Chem., 1992, 35, 1216;
28. (d) J. T. Rhule, C. L. Hill and D. A. Judd, Chem. Rev., 1998, 98, 327;
29. (e) M. Witvrouw, H. Weigold, C. Pannecouque, D. Schols, E. De Clercq and G. Holan, J. Med. Chem., 2000, 43, 778;
30. (f) D. A. Judd, J. H. Nettles, N. Nevins, J. P. Snyder, D. C. Liotta, J. Tang, J. Ermolieff, R. F. Schinazi and C. L. Hill, J. Am. Chem. Soc., 2001, 123, 886.
31. (a) Y. Take, Y. Tokutake, Y. Inouye, T. Yoshida, A. Yamamoto, T. Yamase and S. Nakamura, Antiviral Res., 1991, 15, 113;
32. (b) S. Shigeta, S. Mori, J. Watanabe, T. Yamase and R. F. Schinazi, Antiviral. Chem. Chemother., 1996, 7, 346;
33. (c) S. Shigeta, S. Mori, J. Watanabe, S. Soeda, K. Takahashi and T. Yamase, Antimicrob. Agents Chemother., 1997, 41, 1423.
34. S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi and T. Yamase, Antiviral Res., 2003, 58, 265.
35. M. V. da Silva Coimbra, M. C. Silva-Carvalho, H. Wisplinghoff, G. O. Hall, S. Tallent, S. Wallace, M. B. Edmond, A. M. Figueiredo and R. P. Wenzel, J. Hosp. Infect., 2003, 53, 103-110.
36. (a) H. Hanaki, K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinaki and K. Hiramatsu, J. Antimicrob. Chemother., 1998, 42, 199;
37. (b) H. Hanaki, H. Labischinski, Y. Inaba, N. Kondo, H. Murakami and K. Hiramatsu, J. Antimicrob. Chemother., 1998, 42, 315.
38. (a) B. E. Dünn, H. Cohen and M. J. Blaser, Clin. Microbiol. Rev., 1997, 10, 720;
39. (b) A. Leodolter, M. Kulig, H. Brasch, W. Meyer-Sabellek, S. N. Willich and P. Malfertheiner, Aliment. Pharmacol. Ther., 2001, 15, 1949;
40. (c) R. T. Wang, T. Wang, K. Chen, J. Y. Wang, J. P. Zhang, S. R. Lin, Y. M. Zhu, W. M. Zhang, Y. X. Cao, C. W. Zhu, H. Yu, Y. J. Cong, S. Zheng and B. Q. Wu, World J. Gastroenterol., 2002, 8, 1103;
41. (d) L. Marzio, L. Cellini and D. Angelucci, Dig. Liver Dis., 2003, 35, 20.
42. (a) R. P. Logan, P. A. Gummet, J. J. Misiewicz, Q. N. Karim, M. M. Walker and J. H. Baron, Lancet, 1991, 338, 1249;
43. (b) D. Y. Graham, G. M. Lew, H. M. Malaty, D. Evans, P. Klein and L. Alpert, Gastroenterology, 1992, 102, 493;
44. (c) E. Hentchel, G. Brandsätter, B. Dragosics, A. M. Hirschl, H. Nemec, K. Schütze and N. Engl, J. Med., 1993, 328, 308;
45. (d) F. Bazzoli, R. M. Zagari, S. Fossi, P. Pozzato, G. Alampi, P. Simoni, S. Sottili, A. Roda and E. Roda, Eur. J. Gastroenterol. Hepatol., 1994, 6, 773.
46. (a) T. K. Ling, A. F. Cheng, J. J. Sung, P. Y. Yiu and S. S. Chung, Helicobacter, 1996,1, 57;
47. (b) V. Ellenrieder, W. Boeck, C. Richter, R. Marre, G. Adler and B. Glasbrenner, Scand. J. Gastroenterol, 1999, 34, 750.
48. A. Ogata, S. Mitsui, H. Yanagie, H. Kasano, T. Hisa, T. Yamase and M. Eriguchi, Biomed. Pharmacother., 2005, 59, 240.
49. Y. Shen, Z. X. Shen, H. Yan, J. Chen, X. Y. Zeng, J. M. Li, W. Wu, S. M. Xiong, W. I. Zhao, W. Tang, F. Wu, Y. F. Liu, C. Miu, Z. Y. Wang, S. J. Chen and Z. Chen, Leukemia, 2001, 15, 735.
50. M. Kito, K. Matsumoto, N. Wada, K. Sera, S. Futatsugawa, T. Naoe, Y. Nozawa and Y. Akao, Cancer Sci., 2003, 94, 1010.
51. (a) R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijin, J. Desmyter and E. De Clercq, J. Virol. Methods, 1988, 20, 309;
52. (b) W. Watanabe, K. Konno, K. Ijichi, H. Inoue, T. Yokota and S. Shigeta, J. Virol. Methods, 1994, 48, 257;
53. (c) S. Mori and S. Shigeta, Tohoku J. Exp. Med., 1995, 177, 315.
54. J. Kimpton and M. Emerman, J. Virol, 1992, 66, 2232.
55. G. A. Donzella, D. Schols, S. W. Lin, J. A. Esté, K. A. Nagashima, P. J. Maddon, G. P. Allaway, T. P. Sakmar, G. Henson, E. De Clercq and J. P. Moore, Nature Med., 1998, 4, 72.
56. Y. Inouye, Y. Fujimoto, M. Sugiyama, T. Yoshida and T. Yamase, Biol. Pharm. Bull., 1995, 18, 996.
57. S. Shigeta, S. Mori, J. Watanabe, M. Baba, A. M. Khenkin, C. L. Hill and R. F. Schinazi, Antiviral Chem. Chemother., 1995, 6, 114.
58. (a) D. O. Andersen, B. K. Murray and J. A. North, Antiviral Chem. Chemother., 1993, 4, 249;
59. (b) B. F. Gilbert and V. Knight, Antimicrob. Agents Chemother., 1986, 30, 201.
60. S. Ikeda, S. Nishiya, A. Yamamoto, T. Yamase, C. Nishimura and E. De Clercq, J. Med. Virol., 1993, 41, 191.
61. (a) K. Ubukata, N. Yamashita and M. Konno, Antimicrob. Agents Chemother., 1985, 27, 851;
62. (b) M. Matsuhashi, M. D. Song, F. Ishino, M. Wachi, M. Doi, M. Inoue, K. Ubukata, N. Yamashita and M. Konno, J. Bacteriol., 1986, 167, 975;
63. (c) K. Hiramatsu, Microbiol. Immunol., 1995, 39, 531;
64. (d) H. F. Chambers, Clin. Microbiol. Rev., 1997, 10, 781.
65. M. Matsuhashi, M. D. Song, F. Ishino, M. Wachi, M. Doi, M. Inoue, K. Ubukata, N. Yamashita and M. Konno, J. Bacterial, 1986, 167, 975.
66. M. Inoue, K. Segawa, S. Matsunaga, N. Matsumoto, M. Oda and T. Yamase, J. Inorg. Biochem., 2005, 99, 1023.
67. D. J. Waxman and J. L. Strominger, Ann. Rev. Biochem., 1983, 52, 825.
68. S. Pestka, Annu. Rev. Microbiol., 1971, 25, 487.
69. (a) R. C. Knight, I. M. Skolimowski and D. I. Edwards, Biochem. Pharmacol., 1978, 27, 2089;
70. (b) M. Müller, Surgery, 1983, 93, 165.